The work reported here was conducted subsequent to the subsidie toekenningsbrief of 29 October 1997 (Ministerial reference CSZ/ZT/9713672), which was in turn based upon a Ministerial letter to the Tweede Kamer of April 1997 "MTA en doelmatigheid van zorg" (Ministerial reference CSZ/EZ-974801). Based on this Ministerial letter, a large programme "Herijking Richtlijnen en Richtlijn Implementatie" on guideline development and implementation began in the Netherlands. The RAND Europe project within this programme was aimed at understanding how to assess the likely consequences of the development and implementation of guidelines for clinical practice, with particular reference to coronary artery disease and clinical depression.
This report is part of the RAND Corporation RAND Europe document series. RAND Europe reports (RE) were monograph/reports (MR) produced by RAND Europe. REs were published at RAND from 1998 to 2001. RAND monograph/reports presented major research findings that addressed the challenges facing the public and private sectors.
Permission is given to duplicate this electronic document for personal use only, as long as it is unaltered and complete. Copies may not be duplicated for commercial purposes. Unauthorized posting of RAND PDFs to a non-RAND Web site is prohibited. RAND PDFs are protected under copyright law. For information on reprint and linking permissions, please visit the RAND Permissions page.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.